Skip to main content
. 2018 Sep 25;19(11):1065–1071. doi: 10.1080/15384047.2018.1480291

Figure 1.

Figure 1.

FOXD4 was over-expressed in CRC and was associated with poor survival. (A-B) The expression of FOXD4 was examined by quantitative real-time PCR of colorectal cancer tissues and adjacent noncancerous tissues. (C-D) The expression of FOXD4 was examined by western blots derived from colorectal cancer tissues and adjacent noncancerous tissues. (E-F) The expression of FOXD4 as documented for CRC cohorts on TCGA and GEO databases. (F-G) The Kaplan-Meier method was used to analyze the overall survival and recurrence-free survival of patients based on their FOXD4 levels. (*p < 0.05, **p < 0.01, ***p < 0.001).